{"schema_version":"1","generated_at":"2026-10-28T22:39:02.971Z","data_as_of":null,"url":"https://www.findmykol.com/kol/roby-thomas","json_url":"https://www.findmykol.com/kol/roby-thomas/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"roby-thomas","name":"Roby Thomas","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Pittsburgh","institution_url":"https://www.findmykol.com/institution/university-of-pittsburgh","city":"Pittsburgh","state":"PA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1912266735","orcid":"0000-0003-4828-4586","openalex":"A5052508283"},"summary":"Roby Thomas is an Oncology physician affiliated with University of Pittsburgh. OpenAlex indexes 46 publications with 417 citations (h-index 8).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":46,"cited_by_count":417,"h_index":8,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":10,"program_years":{"first":2021,"last":null},"rows_total":15,"shown":3,"withheld":12,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":68.49,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1912266735"},{"payer":"Caris MPI, Inc.","program_year":2025,"amount_usd":27.71,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1912266735"},{"payer":"Celgene Corporation","program_year":2025,"amount_usd":13.48,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1912266735"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1912266735","source":"payments"},"prescribing":{"data_year":2024,"areas_total":5,"areas_shown":3,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":44.7,"classes_total":4,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":31.4,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":40},{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":5.8,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":14}]},{"area":"Cancer & immunology","share_pct":33.2,"classes_total":3,"classes":[{"class":"Cytochrome P450 17A1 Inhibitor","setting":"prescribed","share_pct":13.6,"drugs":[{"name":"Abiraterone Acetate","share_pct":100}],"max_beneficiaries":16},{"class":"Gonadotropin Releasing Hormone Receptor Antagonist","setting":"prescribed","share_pct":13.1,"drugs":[{"name":"Orgovyx","share_pct":100}],"max_beneficiaries":17}]},{"area":"Nervous system","share_pct":9.3,"classes_total":2,"classes":[{"class":"Gabapentinoids","setting":"prescribed","share_pct":6,"drugs":[{"name":"Gabapentin","share_pct":100}],"max_beneficiaries":null},{"class":"Phenothiazine","setting":"prescribed","share_pct":3.3,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":66.7,"facility_pct":33.3},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Extraction of Treatments and Responses From Non–Small Cell Lung Cancer Clinical Notes Using Natural Language Processing","year":2026,"journal":"JCO Clinical Cancer Informatics","source_url":"https://doi.org/10.1200/cci-25-00138","status":"verified"},{"title":"Clinical outcomes in the real-world utilization of 177Lu-PSMA 617 in metastatic castrate-resistant prostate cancer.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.7_suppl.104","status":"verified"},{"title":"Clinician Perspectives on Integrating Mobile Sensor Data Into Cancer Care: Mixed Methods Study","year":2026,"journal":"JMIR Cancer","source_url":"https://doi.org/10.2196/86412","status":"verified"},{"title":"Real-world ARPI utilization patterns and outcomes in metastatic castration-sensitive prostate cancer.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.7_suppl.119","status":"verified"},{"title":"Real-world time to next treatment in metastatic urothelial cancer patients: Enfortumab vedotin and pembrolizumab vs chemotherapy as first-line treatment.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.7_suppl.707","status":"verified"}],"source":"works"},"contact":{"address_1":"5115 CENTRE AVE","address_2":"3RD FLOOR","city":"Pittsburgh","state":"PA","zip":"152321301","phone":"412-235-1020","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1912266735","source":"identity"},"similar":[{"name":"Norman Wolmark","slug":"norman-wolmark","institution":"University of Pittsburgh","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/norman-wolmark","json_url":"https://www.findmykol.com/kol/norman-wolmark/profile.json"},{"name":"Sally Wenzel","slug":"sally-wenzel","institution":"University of Pittsburgh","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/sally-wenzel","json_url":"https://www.findmykol.com/kol/sally-wenzel/profile.json"},{"name":"Mary Phillips","slug":"mary-phillips","institution":"University of Pittsburgh","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/mary-phillips","json_url":"https://www.findmykol.com/kol/mary-phillips/profile.json"},{"name":"Udai Kammula","slug":"udai-kammula","institution":"University of Pittsburgh","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/udai-kammula","json_url":"https://www.findmykol.com/kol/udai-kammula/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":12,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-09-23","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}